CareLit Fachartikel

Botulinum toxin within the muscle – MRI follow up in children with spastic cerebral palsy supports neurogenic atrophy in healthy muscle one year after a single injection of botuli…

S Schröder, I Koerte, JM Schröder, I Borggräfe, K Huß, B Ertl-Wagner, F Heinen, S Berweck · Klinische Neurophysiologie · 2010 · Heft 03

Dokument
1077536
CareLit-ID
Jahr
2010
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Neurophysiologie
Autor:innen
S Schröder, I Koerte, JM Schröder, I Borggräfe, K Huß, B Ertl-Wagner, F Heinen, S Berweck
Ausgabe
Heft 03 / 2010
Seiten
–
Erschienen: 2010-03-02 00:00:00
ISSN
1434-0275

Zusammenfassung

Introduction: Botulinum toxin is widely used as a therapeutic option to reduce (multi-) focal muscle hypertension as well as for cosmetic indications. Recommendations on reinjection intervals (3–12months) are based on clinical observation and basic science research using animal models. Morphologic long-term alterations following a single injection of botulinum toxin are scarce. With the development of short tau inversion recovery (STIR) sequences Magnetic resonance imaging (MRI) is able to detect neurogenic muscle atrophy over the course of time. The aim of this study was to investigate the neurogenic atrophy in…

Schlagworte

Klinische Neurophysiologie